公司概覽
業務類別 --
業務概覽 FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.
公司地址 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401
電話號碼 +1 612 800-0059
傳真號碼 --
公司網頁 https://foxotechnologies.com
員工數量 192
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jon R. Sabes Chief Executive Officer and Chairman of the Board -- 30/08/2022
Mr. Michael P. Williams General Counsel -- 04/05/2023
Mr. Seamus Lagan Director, Chief Executive Officer and Interim Chief Financial Officer and Principal Accounting Officer -- 13/06/2025
Mr. Martin Ward Interim Chief Financial Officer and Principal Accounting Officer -- 15/04/2025
Mr. Bryce Quin, C.P.A. Chief Financial Officer, Principal Accounting Officer and Secretary -- 07/03/2022
Mr. Brian Chen Chief Science Officer 美元 236.00K 04/05/2023
Mr. Erin Sharoni Chief Product Officer -- 30/08/2022
Mr. Robert Potashnick Chief Financial Officer and Principal Accounting Officer 美元 205.00K 18/08/2023
Mr. Tyler Danielson Chief Technology Officer and Interim Chief Executive Officer 美元 205.00K 04/05/2023
Mr. Taylor Fay Chief Operating Officer -- 18/04/2023
Mr. Mark White Director; Chief Executive Officer of FOXO Labs Inc. -- 15/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Jon R. Sabes Chief Executive Officer and Chairman of the Board 30/08/2022
Mr. Seamus Lagan Director, Chief Executive Officer and Interim Chief Financial Officer and Principal Accounting Officer 13/06/2025
Mr. Trevor Langley Chairman of the Board 15/04/2025
Mr. Michael T. Gray Director 07/03/2022
Mr. Andrew J. Poole Independent Director 04/05/2023
Senator E. Benjamin Nelson Independent Director 07/03/2022
Mr. Paul Britton Newhouse Independent Director 07/03/2022
Ms. Ryan Rugg Independent Director 07/03/2022
Mr. Bret Barnes Independent Director 15/04/2025
Dr. Murdoc Khaleghi, M.D. Independent Director 04/05/2023
Mr. Mark White Director; Chief Executive Officer of FOXO Labs Inc. 15/04/2025
Mr. Francis Colt deWolf, III Independent Director 15/04/2025
 
所屬ETF (更新日期: 30/07/2026 07:30)
代號 名稱 佔比% 持有日期
BRWSaba Capital Income & Opportunities Fund0.34%31/10/2021
RIVRiverNorth Opportunities0.25%30/04/2022
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.